[ad_1]
Watch CBS News
Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.
[ad_2]

[ad_1]
Watch CBS News
Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.
[ad_2]

[ad_1]
CNN
—
In September, an 8-month-old baby came into Dr. Juanita Mora’s office in Chicago with an infection the doctor hadn’t expected to see for another two months: RSV.
Like her peers across the country, the allergist and immunologist has been treating little ones with this cold-like virus well before the season usually starts.
“We’re seeing RSV infections going rampant all throughout the country,” Mora said.
Almost all children catch RSV at some point before they turn 2, the US Centers for Disease Control and Prevention says. Most adults who catch it have a mild illness; for those who are elderly or who have chronic heart or lung disease or a weakened immune system, it can be dangerous. But RSV can be especially tricky for infants and kids.
Mora, a volunteer medical spokesperson for the American Lung Association, says it’s important for parents, caregivers and daycare workers to know what to watch for with RSV, which stands for respiratory syncytial virus. That way, they know whether a sick child can be treated at home or needs to go to a hospital.
“The emergency department is getting completely flooded with all these sick kids, so we want parents to know they can go to their pediatrician and get tested for RSV, influenza and even Covid-19,” Mora said.
Here’s what else parents need to know amid the surge of respiratory illnesses.
For many, RSV causes a mild illness that can be managed at home.
On average, an infection lasts five days to a couple of weeks, and it will often go away on its own, the CDC says. Sometimes, the cough can linger for up to four weeks, pediatricians say.
Symptoms may look like a common cold: a runny nose, a decreased appetite, coughing, sneezing, fever and wheezing. Young infants may seem only irritable or lethargic and have trouble breathing.
Not every child will have every potential RSV symptom.
“Fevers are really hit or miss with RSV infections, especially in young infants,” said Dr. Priya Soni, assistant professor of pediatric infectious diseases at Cedars Sinai Medical Center.
Parents should watch for any changes in behavior, she said, including taking longer to eat or not being interested in food at all. The child can also develop a severe cough and some wheezing.
It’s also important to watch for signs that your child is struggling to breathe or breathing with their ribs or belly – “symptoms which may kind of overlap with many of the other viruses that we’re seeing a resurgence of,” Soni added.
Since it’s not easy for parents to tell the difference between respiratory illnesses like, say, RSV and flu, it’s good to take a sick child to a pediatrician, who can run tests to pinpoint the cause.
“You may need to take your baby to be evaluated sooner rather than later,” Soni said.
When it comes to RSV, parents should be especially cautious if their children are preemies, newborns, children with weakened immune systems or neuromuscular disorders, and those under age 2 with chronic lung and heart conditions, the CDC says.
“Parents should be really astute to any changes, like in their activity and their appetite, and then pay particular attention to any signs of respiratory distress,” Soni said.
Testing is important because treatment for things like flu and Covid-19 may differ.
There’s no antiviral or specific treatment for RSV like there is for the flu, nor is there a vaccine. But if your child is sick, there are things you can do to help.
Fever and pain can be managed with non-aspirin pain relievers like acetaminophen or ibuprofen. Also make sure your child drinks enough fluids.
“RSV can make kids very dehydrated, especially when they’re not eating or drinking, especially when we’re talking infants,” Mora said. “Once they stop eating or their urine output has decreased, they’re not having as many wet diapers, this is a sign they may have to go to the pediatrician or emergency department.”
Talk to your pediatrician before giving your child any over-the-counter cold medicines, which can sometimes contain ingredients that aren’t good for kids.
Your pediatrician will check the child’s respiratory rate – how fast they’re breathing – and their oxygen levels. If your child is very sick or at high risk of severe illness, the doctor may want them to go to a hospital.
“RSV can be super dangerous for some young infants and younger kids, particularly those that are less than 2 years of age,” Soni said.
Mora said labored breathing is a sign that a child is having trouble with this virus. RSV can turn into more serious illnesses such as bronchiolitis or pneumonia, and that can lead to respiratory failure.
If you see that a child’s chest is moving up and down when they breathe, if their cough won’t let them sleep or if it’s getting worse, “that might be a sign that they need to seek help from their pediatrician or take them to the emergency department, because then they might need a supplemental oxygen, or they may need a nebulization treatment.”
CNN medical analyst Dr. Leana Wen says this respiratory difficulty – including a bobbing head, a flaring nose or grunting – is one of two major trouble signs with any respiratory infection. The other is dehydration. “That particularly applies to babies with stuffy noses. They may not be feeding.”
Much of the care provided by hospital staff will be to help with breathing.
“We provide supportive measures for RSV and these kids with oxygen, IV fluids and respiratory therapies, including suctioning,” Soni said.
A thin tube may need to be inserted into their lungs to remove mucus. A child can get extra oxygen through a mask or through a tube that attaches to their nose. Some children may need to use an oxygen tent. Those who are struggling a lot may need a ventilator.
Some babies might also need to be fed by tube.
The best ways to prevent RSV infections, doctors say, is to teach kids to cough and sneeze into a tissue or into their elbows rather than their hands. Also try to keep frequently touched surfaces clean.
If a caregiver or older sibling is sick, Mora says, they should wear a mask around other people and wash their hands frequently.
And most of all, if anyone is sick – child or adult – they should stay home so they don’t spread the illness.
There is a monoclonal antibody treatment for children who are at highest risk for severe disease. It’s not available for everyone, but it can protect those who are most vulnerable. It comes in the form of a shot that a child can get every month during the typical RSV season. Talk to your doctor about whether your child qualifies.
[ad_2]
[ad_1]
The Centers for Disease Control and Prevention has refuted claims that it’s planning to add the COVID-19 vaccine to immunization schedules for schoolchildren, saying that the authority for that decision lies with states and other local entities.
The false claim spread after it was shared by Fox News host Tucker Carlson in a tweet this week, as the Associated Press reported.
Carlson tweeted that the agency would make the vaccine mandatory in order for children to attend school, a claim the CDC quickly shot down. While an advisory committee to the CDC voted to recommend that the vaccine be added to immunization schedules, the CDC “only makes recommendations for use of vaccines, while school-entry vaccination requirements are determined by state or local jurisdictions,” CDC spokeswoman Kate Grusich told the AP.
Grusich explained that the action was meant to streamline clinical guidance for healthcare providers by adding COVID-19 vaccines to a single list of all currently licensed, authorized and routinely recommended vaccines.
“It’s important to note that there are no changes in COVID-19 vaccine policy,” she said.
The news comes as U.S. known cases of COVID are continuing to ease and now stand at their lowest level since mid-April, although the true tally is likely higher given how many people overall are testing at home, where data are not being collected.
The daily average for new cases stood at 38,077 on Thursday, according to a New York Times tracker, down 8% from two weeks ago. Cases are currently rising in 14 states, as well as Washington, D.C., and Puerto Rico.
The daily average for hospitalizations was down 2% to 26,669, although hospitalizations are rising in almost all northeastern states as cold weather arrives. The daily average for deaths was down 7% to 360.
Coronavirus Update: MarketWatch’s daily roundup has been curating and reporting all the latest developments every weekday since the coronavirus pandemic began
Other COVID-19 news you should know about:
• Pfizer
PFE,
is planning to sell the COVID vaccine it developed with German partner BioNTech
BNTX,
for $110 -$130 a dose once the U.S. market for COVID-19 shots becomes commercial, likely in the first quarter of next year, MarketWatch’s Jaimy Lee reported. Pfizer and BioNTech are currently paid $30.50 per vaccine dose by the U.S. government, which contracted with the companies, as well as with other vaccine makers like Moderna
MRNA,
and Novavax
NVAX,
and then made the COVID-19 shots available at no cost to people in the U.S. during the public-health emergency. The emergency declaration in the U.S. isn’t expected to be renewed next year, which will lead to the formation of an official commercial market for COVID-19 vaccines, tests and treatments.
• Johnson & Johnson
JNJ,
said the volume of surgical procedures is returning to prepandemic levels in many parts of the world, a trend that cheered Wall Street and could bode well for other medical-technology heavyweights like Stryker Corp.
SYK,
and Zimmer Biomet Holdings
ZBH,
J&J, which reported earnings this week, said its medical-technology business had a “strong September,” with U.S. sales of hip and knee implants and other surgical devices rising 7.7% to $3.3 billion in the third quarter of the year. “We are seeing procedures recovering,” Ashley McEvoy, worldwide chair of J&J’s MedTech business, told investors during this week’s earnings call. “In the U.S., we started to see surgical procedures tick up, predominantly at the latter part of the quarter.”
• “As China’s ruling Communist Party holds a congress this week, many Beijing residents are focused on an issue not on the formal agenda: Will the end of the meeting bring an easing of China’s at times draconian ‘zero-COVID’ policies that are disrupting lives and the economy?” the AP reported. It appears to be wishful thinking. As the world moves to a postpandemic lifestyle, many across China have resigned themselves to lining up several times a week for COVID tests, restrictions on travel to other regions and the ever-present possibility of a community lockdown.
• Fantasy Fest, a 10-day annual party, is kicking off in Key West, Fla., on Friday, with a full slate of events for the first time since the pandemic started, the AP reported. “Due to the COVID pandemic, this will be the first full Fantasy Fest since 2019,” the festival’s board chair, Steve Robbins, said. “So I know our guests and staff are excited about getting back to the real Fantasy Fest.” Dozens of themed events are set for the festival, including a nighttime parade Oct. 29 featuring floats and elaborately costumed marching groups. Participants are encouraged to draw costume ideas from the festival’s theme, “Cult Classics & Cartoon Chaos,” and to portray characters inspired by favorite cartoons and television or film productions with a cult following.
Here’s what the numbers say:
The global tally of confirmed cases of COVID-19 topped 626.9 million on Friday, while the death toll rose above 6.57 million, according to data aggregated by Johns Hopkins University.
The U.S. leads the world with 97.2 million cases and 1,067,190 fatalities.
The Centers for Disease Control and Prevention’s tracker shows that 226.5 million people living in the U.S., equal to 68.2% of the total population, are fully vaccinated, meaning they have had their primary shots. Just 111.4 million have had a booster, equal to 49.1% of the vaccinated population, and 26.8 million of those who are eligible for a second booster have had one, equal to 40.6% of those who received a first booster.
The CDC reports that some 19.4 million people have had a dose of the updated bivalent booster that targets omicron and its subvariants along with the original virus.
[ad_2]

[ad_1]
By Steven Reinberg
HealthDay Reporter
FRIDAY, Oct. 21, 2022 (HealthDay News) — Victims of sexual assault are seeking treatment in U.S. emergency rooms in growing numbers, with University of Michigan (UM) researchers detecting a 15-fold increase between 2006 and 2019.
Rapes and other forms of sexual assault occur every 68 seconds in the United States, and their number rose from 93,000 in 2006 to nearly 140,000 in 2019, according to data from the U.S. Federal Bureau of Investigation.
The increase in people seeking emergency medical care after sexual violence, however, is greater than the growth of those turning to the police for help, the study authors said.
And while there are more sexual assaults occurring, greater awareness and hospital coding changes are also contributing to the spike, the researchers noted.
“Overall destigmatization — whether that’s due to the Me-Too movement or other social-political movements — have made people feel safer coming and seeking care,” said lead researcher Emily Vogt, a UM medical student.
It’s not clear if people who go to the ER after a sexual assault are not going to the police, Vogt added. Perhaps “they feel like that’s the only place they can go,” she said.
For the study, Vogt and her colleagues used data from millions of emergency department visits. They found that in 2006, more than 3,600 men and women aged 18 to 65 sought emergency care following a sexual assault. In 2019, that number jumped to nearly 55,300. (For support, contact RAINN, the Rape, Abuse and Incest National Network hotline).
Vogt’s team found that those seeking ER treatment were disproportionally younger women and poorer.
However, despite the rise in ER care, hospital admissions after a sexual assault decreased by 8% — from just under 13% to 4%. Most patients (95%) were sent home, the findings showed.
Admissions may have dropped because of lack of insurance, fewer empty beds, or victims not wanting to be hospitalized due to privacy concerns, Vogt said.
Patients who were admitted tended to be poorer and have Medicaid. Victims aged 46 to 65 were also more likely to be hospitalized than younger people, possibly because the assault exacerbated other medical conditions, Vogt said.
Overall, emergency department visits increased by 23% during the same period, with sexual assault accounting for less than 1% of visits. Yet hospital charges for sexual assault visits topped $233 million in 2019, up from $6 million in 2006, the researchers reported.
ERs can do better in helping patients after a sexual assault, Vogt said. “The emergency department, even though it’s a better place to go than nowhere, is probably not the best place. We need better kinds of outpatient care,” she suggested.
Vogt anticipates sexual assault numbers will continue to swell. “We didn’t even get to look at the years of the COVID-19 pandemic, which we already know from other studies has certainly increased rates of sexual assault,” she explained.
“A lot of these patients are getting sent home, and it’s unclear whether they are getting the attention they deserve,” Vogt said. “We know these patients are at higher risk for [post-traumatic stress disorder], substance abuse, and psychiatric problems as a result of the trauma they’ve experienced.”
The report was published online Oct. 20 in JAMA Network Open.
Dr. Elizabeth Miller is a professor of pediatrics at the University of Pittsburgh School of Medicine. She said sexual violence remains a significant public health concern.
“Sexual violence reporting and care-seeking is not evenly distributed across populations, and inequities persist,” Miller said. “The health consequences of sexual violence remain underrecognized by our health system, especially among survivors who are marginalized because of sexism, racism, heterosexism and ableism,” added Miller, co-author of an accompanying journal editorial.
Miller agreed there is both increased awareness of sexual violence and growing incidence.
“As a result of lots of community campaigns to make the experiences of sexual assault more visible, more people appear to be seeking care. But it does appear globally, we saw an increase in interpersonal violence, including childhood sexual abuse, sexual assault and intimate partner violence during the pandemic,” she said.
And, she pointed out that people who are already marginalized because of gender identity, sexual minorities, females and people with disabilities experience higher incidences of sexual violence.
Miller added that survivors of sexual assault should expect to be treated with respect by law enforcement and by emergency room staff. “They should know that they can also ask for a trained sexual assault nurse examiner, and they can also ask for a victim services advocate to be present during a forensic exam,” she said.
However, more is needed to improve survivor-centered care in ERs. “We need to understand how best to provide meaningful support for survivors and to not contribute to retraumatizing individuals who have experienced an assault,” Miller said.
[ad_2]

[ad_1]
Employers typically offer a period of open enrollment in the fall, when their workers are allowed to pick new health plans, enroll in a Flexible Spending Account or make other changes to their benefits. This year, there are some changes ahead that could help employees, while also potentially opening up some financial pitfalls.
Among the biggest changes for 2023 are with two tax-advantaged health savings accounts — Flexible Spending Accounts (FSA) and Health Savings Accounts (HSA). These accounts can save workers a nice chunk of change by allowing them to sock away pre-tax money to pay for medical expenses. Basically, you save what you would have paid in taxes on money you put in the accounts.
In 2023, employees can put away as much as $3,050 in an FSA, an increase of about 7% from the current tax year’s cap of $2,850. Meanwhile, single workers who want to fund an HSA can save up to $3,850 next year, a 5.5% increase from 2022, while families can save up to $7,750, up 6.2%.
Those increases are helpful at a time when inflation is at it highest in four decades, with consumer prices having jumped more than 8% from a year ago. But there are several “gotchas” that workers need to be aware of, especially when it comes to Flexible Spending Accounts, with the foremost being that FSAs are “use-it-or-lose-it” programs. In other words, if you don’t use all the money you set aside, you’ll lose it — your employer keeps any unused funds.
“Open enrollment typically opens in late October and early November,” said Lisa Myers, director of client services, benefits accounts, at Willis Towers Watson. “Planning carefully is important, and knowing the deadlines.”
Indeed, U.S. workers end up forfeiting a total of about $3 billion a year in unused FSA funds, according to an analysis from Money.
Here’s what to consider during open enrollment.
Both accounts are aimed at helping workers pay for medical expenses with pre-tax money. The biggest difference is that FSAs are controlled by your employer, while HSAs are owned by the individual.
That means that if you leave your job, your FSA won’t move with you. But once you open and fund an HSA, that account does stay with you, like your 401(k), which continues to be yours even after you leave a job and start at a new employer.
Another big difference: Health Savings Accounts are designed for people with high-deductible health care plans. This means that not every employee will have access to an HSA.
HSAs generally have more flexibility than FSAs. For instance, unused funds roll over each year, unlike with a FSA, where funds are forfeited if not used by your employer’s claim deadline. And you can change your contributions to your HSA at any time; with a FSA, contributions are set during open enrollment.
Generally, no, noted Myers of Willis Towers Watson. However, people with HSAs can opt for a slimmed-down version of a Flexible Spending Account, known as a “limited purpose FSA.” These accounts can only be used for vision and dental expenses, which shrinks their usefulness.
That means employees who qualify for both programs will generally need to decide whether it makes more sense to fund either an FSA or an HSA for 2023.
Some employers offer tools to help workers estimate their potential annual health costs, but you can also look at your out-of-pocket medical expenses for the past year to help gauge your likely expenditures for the upcoming year, Myers said.
People with HSAs also may want to set aside the amount that they’ll pay due to their health plan deductible, since that’s out-of-pocket spending that they could get reimbursed through that tax-advantaged account.
There’s more at stake for people who are opting for FSAs, since overestimating your medical expenses could leave money sitting in your account that eventually returns to your employer.
You’ll need to stay on top of the deadline for claiming your FSA funds.
Employers can give employees a grace period of up to two and a half months after the end of a calendar year to claim the money. But you’ll have to check if your company offers extra time and mark on your calendar when you’ll need to claim the money by.
Some employees may be surprised by deadlines this year because a pandemic stimulus bill and the IRS relaxed the rules for claiming FSA funds, providing more time for people to file claims in 2020 and 2021. But those provisions have expired, which means people with FSAs in 2022 must claim their money by year-end or by an employer’s grace period in early 2023.
“That was temporary relief due to the pandemic, so employees may have larger than usual balances in their health and dependent-care FSAs, and that they may forfeit going into 2023,” Myers said. “It’s important to check your balances, check the plan rules, so they can plan their spending for the remainder of 2022.”
Employees are sometimes surprised at what their FSA plans will cover, including Band-Aids, reading glasses, first-aid kits and over-the-counter medicine, Myers said.
She recommends that people check the FSAStore.com, which carries all FSA-eligible items, especially if you are getting close to your deadline for claiming your funds and need to use the money.
Myers also advises that you check your 2022 FSA balance and claim deadlines now, rather than waiting until the end of the year. Generally, a health service or good must be purchased in 2022 to qualify for a 2022 FSA claim, so waiting until the last minute to try to spend the funds could increase your risk of running into a barrier — such as if your eye doctor is booked up, which could hinder renewing your prescription to get new glasses.
[ad_2]
[ad_1]
The two newly identified omicron subvariants, dubbed BQ.1 and BQ.1.1, are spreading fast in the New York region and could account for about 37% of new cases, according to Centers for Disease Control and Prevention data crunched by NBC News.
The two variants accounted for 11.5% and 8% of new cases, respectively, that were recorded in the area in the week ending Oct. 15, up from 4.1% and 1.9% two weeks earlier. The New York area includes New Jersey, Puerto Rico and the Virgin Islands.
Combined, they accounted for 11.4% of overall U.S. cases in the same week. Before last Friday’s data release, they were included in BA.5 variant data, as the numbers were too small to break out. BQ.1 was first identified by researchers in early September and has been found in the U.K. and Germany, among other places. The CDC is updating the numbers every Friday.
“When you get variants like that, you look at what their rate of increase is as a relative proportion of the variants, and this has a pretty troublesome doubling time,” Anthony Fauci, President Joe Biden’s chief medical adviser, said in an interview with CBS News earlier this week.
The news comes as experts fear another wave of cases during the winter months as colder weather forces people indoors and families gather for holidays.
U.S. known cases of COVID are continuing to ease and now stand at their lowest level since mid-April, although the true tally is likely higher given how many people overall are testing at home, where the data are not being collected.
The daily average for new cases stood at 37,888 on Tuesday, according to a New York Times tracker, down 15% from two weeks ago. Cases are currently rising in 10 states: Nevada, New Hampshire, New Mexico, Oklahoma, Maryland, Wisconsin, Illinois, Vermont, Kansas and Florida. Cases are also rising in Washington, D.C.
The daily average for hospitalizations was down 6% to 25,845, although hospitalizations are up in many northeastern states, including Rhode Island, New Hampshire, New Jersey, New York, Massachusetts, Delaware, Pennsylvania and Maine.
The daily average for deaths is down 3% to 382.
In other news, the World Health Organization said its emergency committee came away from a meeting last week with the determination that the pandemic remains a global health emergency, despite recent progress.
WHO Director General Tedros Adhanom Ghebreyesus said he agreed with that decison.
“The committee emphasized the need to strengthen surveillance and expand access to tests, treatments and vaccines for those most at-risk, and for all countries to update their national preparedness and response plans,” Tedros told reporters at a briefing.
“While the global situation has obviously improved since the pandemic began, the virus continues to change, and there remain many risks and uncertainties,” he said. “This pandemic has surprised us before and very well could again.”
Coronavirus Update: MarketWatch’s daily roundup has been curating and reporting all the latest developments every weekday since the coronavirus pandemic began
Other COVID-19 news you should know about:
• Reports that a 16-year-old girl has died at a COVID quarantine center in China are causing anger after her family said their pleas for medical help were ignored, the Guardian reported. Videos of the girl have spread across Chinese social media in the last 24 hours. The distressing footage, which the Guardian said it has not been able to independently verify, shows the teenager ill, struggling to breathe and convulsing in a bunk bed at what is purported to be a quarantine center in Ruzhou, Henan province. The reports come as Communist Party leaders hold their party congress in Beijing amid anger about the country’s strict zero-COVID policy.
• Hong Kong, which is experiencing a massive brain drain thanks to the pandemic and to political upheaval, unveiled a new visa scheme on Wednesday that aims to attract global talent, the Associated Press reported. The region’s chief executive, John Lee, said the Top Talent Pass Scheme will allow people who earn an annual salary of 2.5 million Hong Kong dollars ($318,472) or more, as well as graduates of the world’s top universities, to work or pursue opportunities in the city for two years.
• The COVID pandemic catalyzed a major shift in the way Americans live and work, and a new analysis from the Federal Reserve Bank of New York shows that workers in the U.S. are taking advantage of the widespread shift toward remote work to spend more time sleeping and engaging in leisure activities, MarketWatch’s Chris Matthews reported. “One of the most enduring shifts [resulting from the pandemic] has occurred in the workplace, with millions of employees making the switch to work from home,” wrote David Dam, a former New York Fed research analyst, in a Tuesday blog post.
• The North Dakota Department of Health stored thousands of COVID-19 vaccine doses at incorrect temperatures or without temperature data over the past two years, according to a state audit Tuesday that said some of those vaccines were administered to patients, the AP reported. The health department disputed the findings. Tim Wiedrich, who heads the agency’s virus response, said “no non-viable vaccine” was given to patients. In responses that accompanied the audit, the department said clerical errors or other errors of documentation erroneously suggested that expired or bad doses were given.
Here’s what the numbers say:
The global tally of confirmed cases of COVID-19 topped 625.7 million on Wednesday, while the death toll rose above 6.57 million, according to data aggregated by Johns Hopkins University.
The U.S. leads the world with 97 million cases and 1,065,841 fatalities.
The Centers for Disease Control and Prevention’s tracker shows that 226.2 million people living in the U.S., equal to 68.1% of the total population, are fully vaccinated, meaning they have had their primary shots. Just 110.8 million have had a booster, equal to 49% of the vaccinated population, and 25.6 million of those who are eligible for a second booster have had one, equal to 39% of those who received a first booster.
Some 14.8 million people have had a dose of the updated bivalent booster that targets omicron and its subvariants along with the original virus.
[ad_2]

[ad_1]
Press Release
–
Oct 18, 2022 16:45 EDT
ATLANTA, October 18, 2022 (Newswire.com)
–
In September 2022, the Substance Abuse and Mental Health Services Administration (SAMHSA) awarded Alliant Health Solutions a three-year grant to establish a national center of excellence for building capacity in nursing facilities to care for residents with behavioral health conditions.
The Center of Excellence for Behavioral Health in Nursing Facilities (COE-NF) will serve as a centralized hub and national model for expanding capacity in nursing facilities to care for residents with a variety of behavioral health needs. The program will support resource development and dissemination to better serve residents with Serious Mental Illness (SMI), Serious Emotional Disturbance (SED), Substance Use Disorders (SUD), or Co-occurring Disorders (COD). Training, technical assistance, and workforce development will be provided for staff in nursing facilities.
SAMHSA expects that this program will help to: (1) strengthen and sustain effective behavioral health practices and achieve better outcomes for nursing home residents with SMI, SED, SUD, or COD; and (2) ensure the availability of evidence-based training and technical assistance addressing mental health disorder identification, treatment, and recovery support services. Training and technical assistance will also be provided to support facilities in improving care for this population.
“Alliant recognizes that mental health is an important part of someone’s overall health and well-being. Our support for the Center of Excellence Nursing Facility will provide necessary resources to support the nursing facility residents that have been diagnosed with behavioral health needs and will also increase awareness about how mental health and substance use affects millions of people and their families nationwide,” says Dennis White, President and CEO at Alliant Health Solutions.
For more information about the Center of Excellence Nursing Facility, visit https://bit.ly/COE_BH_NursingFacility or contact Alliant Health Solutions at COEinfo@allianthealth.org.
Source: Alliant Health Solutions
[ad_2]
[ad_1]
This may surprise you: Wall Street analysts expect earnings for the S&P 500 to increase 8% during 2023, despite all the buzz about a possible recession as the Federal Reserve tightens monetary policy to quell inflation.
Ken Laudan, a portfolio manager at Kornitzer Capital Management in Mission, Kan., isn’t buying it. He expects an “earnings recession” for the S&P 500
SPX,
— that is, a decline in profits of around 10%. But he also expects that decline to set up a bottom for the stock market.
Laudan, who manages the $83 million Buffalo Large Cap Fund
BUFEX,
and co-manages the $905 million Buffalo Discovery Fund
BUFTX,
said during an interview: “It is not unusual to see a 20% hit [to earnings] in a modest recession. Margins have peaked.”
The consensus among analysts polled by FactSet is for weighted aggregate earnings for the S&P 500 to total $238.23 a share in 2023, which would be an 8% increase from the current 2022 EPS estimate of $220.63.
Laudan said his base case for 2023 is for earnings of about $195 to $200 a share and for that decline in earnings (about 9% to 12% from the current consensus estimate for 2022) to be “coupled with an economic recession of some sort.”
He expects the Wall Street estimates to come down, and said that “once Street estimates get to $205 or $210, I think stocks will take off.”
He went further, saying “things get really interesting at 3200 or 3300 on the S&P.” The S&P 500 closed at 3583.07 on Oct. 14, a decline of 24.8% for 2022, excluding dividends.
Laudan said the Buffalo Large Cap Fund was about 7% in cash, as he was keeping some powder dry for stock purchases at lower prices, adding that he has been “fairly defensive” since October 2021 and was continuing to focus on “steady dividend-paying companies with strong balance sheets.”
After the market hits bottom, Laudan expects a recovery for stocks to begin next year, as “valuations will discount and respond more quickly than the earnings will.”
He expects “long-duration technology growth stocks” to lead the rally, because “they got hit first.” When asked if Nvidia Corp.
NVDA,
and Advanced Micro Devices Inc.
AMD,
were good examples, in light of the broad decline for semiconductor stocks and because both are held by the Buffalo Large Cap Fund, Laudan said: “They led us down and they will bounce first.”
Laudan said his “largest tech holding” is ASML Holding N.V.
ASML,
which provides equipment and systems used to fabricate computer chips.
Among the largest tech-oriented companies, the Buffalo Large Cap fund also holds shares of Apple Inc.
AAPL,
Microsoft Corp.
MSFT,
Amazon.com Inc.
AMZN,
and Alphabet Inc.
GOOG,
Laudan also said he had been “overweight’ in UnitedHealth Group Inc.
UNH,
Danaher Corp.
DHR,
and Linde PLC
LIN,
recently and had taken advantage of the decline in Adobe Inc.’s
ADBE,
price following the announcement of its $20 billion acquisition of Figma, by scooping up more shares.
To illustrate what a brutal year it has been for semiconductor stocks, the iShares Semiconductor ETF
SOXX,
which tracks the PHLX Semiconductor Index
SOX,
of 30 U.S.-listed chip makers and related equipment manufacturers, has dropped 44% this year. Then again, SOXX had risen 38% over the past three years and 81% for five years, underlining the importance of long-term thinking for stock investors, even during this terrible bear market for this particular tech space.
Here’s a summary of changes in stock prices (again, excluding dividends) and forward price-to-forward-earnings valuations during 2022 through Oct. 14 for every stock mentioned in this article. The stocks are sorted alphabetically:
| Company | Ticker | 2022 price change | Forward P/E | Forward P/E as of Dec. 31, 2021 |
| Apple Inc. |
AAPL, |
-22% | 22.2 | 30.2 |
| Adobe Inc. |
ADBE, |
-49% | 19.4 | 40.5 |
| Amazon.com Inc. |
AMZN, |
-36% | 62.1 | 64.9 |
| Advanced Micro Devices Inc. |
AMD, |
-61% | 14.7 | 43.1 |
| ASML Holding N.V. ADR |
ASML, |
-52% | 22.7 | 41.2 |
| Danaher Corp. |
DHR, |
-23% | 24.3 | 32.1 |
| Alphabet Inc. Class C |
GOOG, |
-33% | 17.5 | 25.3 |
| Linde PLC |
LIN, |
-21% | 22.2 | 29.6 |
| Microsoft Corp. |
MSFT, |
-32% | 22.5 | 34.0 |
| Nvidia Corp. |
NVDA, |
-62% | 28.9 | 58.0 |
| UnitedHealth Group Inc. |
UNH, |
2% | 21.5 | 23.2 |
| Source: FactSet | ||||
You can click on the tickers for more about each company. Click here for Tomi Kilgore’s detailed guide to the wealth of information available free on the MarketWatch quote page.
The forward P/E ratio for the S&P 500 declined to 16.9 as of the close on Oct. 14 from 24.5 at the end of 2021, while the forward P/E for SOXX declined to 13.2 from 27.1.
Don’t miss: This is how high interest rates might rise, and what could scare the Federal Reserve into a policy pivot
[ad_2]
[ad_1]
The Centers for Disease Control and Prevention said a new COVID variant dubbed BQ.1 and a descendant called BQ.1.1 have gained traction in the U.S., accounting for 11.4% of new cases across the nation in the week ending Oct. 15.
The two variants are lineages of BA.5, the omicron subvariant that remains dominant but has shrunk to account for just 67.9% of circulating variants, the agency said in a Friday update. The CDC had previously combined BQ.1 and BQ.1.1 with BA.5 cases because the numbers of the new variants were so small. BQ.1 was first identified by researchers in early September and has been found in the U.K. and Germany, among other places.
New York and New Jersey currently have the highest proportion of BQ.1 and BQ.1.1 infections, at about 20% of overall cases, according to CDC estimates.
“When you get variants like that, you look at what their rate of increase is as a relative proportion of the variants, and this has a pretty troublesome doubling time,” Anthony Fauci, President Joe Biden’s chief medical adviser, said in an interview with CBS News.
Adding to concerns, the variant seems “to elude important monoclonal antibodies,” he added.
Fauci is confident that Moderna
MRNA,
as well as Pfizer
PFE,
and German partner BioNTech
BNTX,
will be able to update boosters to target the new subvariant. “The somewhat encouraging news is that it’s a BA.5 sublineage, so there are almost certainly going to be some cross-protections that you can boost up,” he said.
So far, only 14.8 million people living in the U.S. have taken advantage of the new bivalent boosters that were authorized by the Food and Drug Administration in late August. That’s equal to about 7% of the 209 million who were initially eligible.
The FDA authorized the Pfizer booster for use in people aged 12 and older and the Moderna booster for adults aged 18 and older. Last week, the FDA added children aged 5 to 11 to the Pfizer program and children aged 6 through 17 to the Moderna one.
Experts are concerned that the low number of vaccinations is due to a sense that the pandemic is over and no longer poses a major risk for most people. U.S. cases are steadily declining and now stand at their lowest level since mid-April; however, the true tally is likely higher than the official count, because many people are testing at home, where data are not being collected.
The daily average for new cases stood at 37,649 on Sunday, down 19% from two weeks ago, according to a New York Times tracker.
The daily average for hospitalizations was down 5% to 26,475, while the daily average for deaths was down 8% to 374.
But cold weather is expected to bring a new wave of cases, and hospitalizations are rising again in much of the Northeast, the Times tracker is showing.
“That’s the thing that’s so frustrating for me and for my colleagues who are involved in this, is that we have the capability of mitigating against this. And the uptake of the new bivalent vaccine is not nearly as high as we would like it to be,” said Fauci.
Coronavirus Update: MarketWatch’s daily roundup has been curating and reporting all the latest developments every weekday since the coronavirus pandemic began
Other COVID-19 news you should know about:
• Moderna and Gavi, the Vaccine Alliance, which is supplying vaccines to low- and middle-income countries, have agreed to cancel remaining orders under their 2022 COVID-19 vaccine agreement given “sufficient supply.” The biotechnology company has supplied Gavi with nearly 70 million doses of COVID-19 vaccines, in addition to facilitating the donation of more than 100 million doses. Moderna and Gavi said they will create a new framework that enables Gavi to buy up to 100 million COVID-19 vaccine doses in 2023.
• The World Health Organization, the Food and Agriculture Organization of the United Nations, the United Nations Environment Program and the World Organization for Animal Health on Monday launched a new initiative that aims to address health threats to humans, animals, plants and the environment. The One Health Joint Plan of Action “aims to create a framework to integrate systems and capacity so that we can collectively better prevent, predict, detect, and respond to health threats,” the four agencies said in a statement.
• China is doubling down on its zero-COVID strategy as a historic Communist Party congress opens in Beijing, BBC News reported. Zero COVID was a “people’s war to stop the spread of the virus,” said President Xi Jinping as he kicked off the meeting. There is increasing public fatigue over lockdowns and travel restrictions, and Beijing has come under strict security measures ahead of the congress, sparking frustration in the city, including a rare and dramatic public protest on Thursday criticizing Xi and his strategy.
• Airline stocks rallied Monday after data showed that on Sunday, more people flew than on any other day since before the pandemic. Data from the Transportation Security Administration showed that 2.495 million travelers went through TSA checkpoints on Sunday, which is just above the previous 2022 high of 2.490 million on July 1 and the most since Feb. 11, 2020, which was exactly one month before the World Health Organization declared COVID-19 a global pandemic. In comparison, the day with the fewest travelers since the start of the pandemic was April 12, 2022, with 87,534 people traveling. And in 2019, there were 116 days of more travelers than Sunday, while the average for that year was 2.306 million. The U.S. Global Jets ETF
JETS,
was up 2.2%.
Here’s what the numbers say:
The global tally of confirmed cases of COVID-19 topped 624.7 million on Monday, while the death toll rose above 6.56 million, according to data aggregated by Johns Hopkins University.
The U.S. leads the world with 96.9 million cases and 1,065,118 fatalities.
The Centers for Disease Control and Prevention’s tracker shows that 226.2 million people living in the U.S., equal to 68.1% of the total population, are fully vaccinated, meaning they have had their primary shots. Just 110.8 million have had a booster, equal to 49% of the vaccinated population, and 25.6 million of those who are eligible for a second booster have had one, equal to 39% of those who received a first booster.
[ad_2]

[ad_1]
Oct. 13, 2022 – It’s a devastating series of setbacks for long COVID patients. First, they get the debilitating symptoms of their condition. Then they are forced to give up their jobs, or severely curtail their work hours, as their symptoms linger. And next, for many, they lose their employer-sponsored health insurance.
While not all long COVID patients are debilitated, the CDC’s ongoing survey on long COVID found a quarter of adults with long COVID report it significantly affects their day-to-day living activities.
Estimates have shown that long COVID has impacted the lives of anywhere from 16 million to 34 million Americans between the ages of 18 and 65.
While hard data is still limited, a Kaiser Family Foundation analysis found that more than half of adults with long COVID who worked before getting the virus are now either out of work or working fewer hours.
According to data from the Census Bureau’s Household Pulse Survey, out of the estimated 16 million working-age adults who currently have long COVID, 2 million to 4 million of them are out of work due to their symptoms. The cost of those lost wages ranges from $170 billion a year to as much as $230 billion, the Census Bureau says. And given that approximately 155 million Americans have employer-sponsored health insurance, the welfare of working-age adults may be under serious threat.
“Millions of people are now impacted by long COVID, and oftentimes along with that comes the inability to work,” says Megan Cole Brahim, PhD, an assistant professor in the Department of Health Law, Policy, and Management at Boston University and co-director of the school’s Medicaid Policy Lab. “And because a lot of people get their health insurance coverage through employer-sponsored coverage, no longer being able to work means you may not have access to the health insurance that you once had.”
The CDC defines long COVID as a wide array of health conditions, including malaise, fatigue, shortness of breath, mental health issues, problems with the part of the nervous system that controls body functions, and more.
Gwen Bishop was working remotely for the Human Resources Department at the University of Washington Medical Centers when she got COVID-19. When the infection passed, Bishop, 39, thought she’d start feeling well enough to get back to work – but that didn’t happen.
“When I would log in to work and just try to read emails,” she says, “it was like they were written in Greek. It made no sense and was incredibly stressful.” .
This falls in line with what researchers have found out about the nervous system issues reported by people with long COVID. People who have survived acute COVID infections have reported lasting sensory and motor function problems, brain fog, and memory problems.
Bishop, who was diagnosed with ADHD when she was in grade school, says another complication she got from her long COVID was a new intolerance to stimulants like coffee and her ADHD medication, Vyvanse, which were normal parts of her everyday life.
“Every time I would take my ADHD medicine or have a cup of coffee, I would have a panic attack until it wore off,” says Bishop. “Vyvanse is a very long-acting stimulant, so that would be an entire day of an endless panic attack.”
In order for her to get a medical leave approved, Bishop needed to get documents by a certain date from her doctor’s office that confirmed her long COVID diagnosis. She was able to get a couple of extensions, but Bishop says that with the burden that has been placed on our medical systems, getting in to see a doctor through her employer insurance was taking much longer than expected. By the time she got an appointment, she says, she had already been fired for missing too much work. Emails she provided showing exchanges between her and her employer verify her story. And without her health insurance, her appointment through that provider would no longer have been covered.
In July 2021, the U.S. Department of Health and Human Services issued guidance recognizing long COVID as a disability “if the person’s condition or any of its symptoms is a ‘physical or mental’ impairment that ‘substantially limits’ one or more major life activities.”
But getting access to disability benefits hasn’t been easy for people with long COVID. On top of having to be out of work for 12 months before being able to qualify for Social Security Disability Insurance, some of those who have applied say they have had to put up a fight to actually gain access to disability insurance. The Social Security Administration has yet to reveal just how many applications that cited long COVID have been denied so far.
David Barnett, a former bartender in the Seattle area in his early 40s, got COVID-19 in March 2020. Before his infection, he spent much of his time working on his feet, bodybuilding, and hiking with his partner. But for the last nearly 3 years, even just going for a walk has been a major challenge. He says he has spent much of his post-COVID life either chair-bound or bed-bound due to his symptoms.
He is currently on his partner’s health insurance plan but is still responsible for copays and out-of-network appointments and treatments. After being unable to bartend any more, he started a GoFundMe account and dug into his personal savings. He says he applied for food stamps and is getting ready to sell his truck. Barnett applied for disability in March of this year but says he was denied benefits by the Social Security Administration and has hired a lawyer to appeal.
He runs a 24-hour online support group on Zoom for people with long COVID and says that no one in his close circle has successfully gotten access to disability payments.
Alba Azola, MD, co-director of Johns Hopkins School of Medicine’s Post-Acute COVID-19 Team, says at least half of her patients need some level of accommodations to get back to work; most can, if given the proper accommodations, such as switching to a job that can be done sitting down, or with limited time standing. But there are still patients who have been more severely disabled by their long COVID symptoms.
“Work is such a part of people’s identity. The people who are very impaired, all they want to do is to get back to work and their normal lives,” she says.
Many of Azola’s long COVID patients aren’t able to return to their original jobs. She says they often have to find new positions more tailored to their new realities. One patient, a nurse and mother of five who previously worked in a facility where she got COVID-19, was out of work for 9 months after her infection. She ultimately lost her job, and Azola says the patient’s employer was hesitant to provide her with any accommodations. The patient was finally able to find a different job as a nurse coordinator where she doesn’t have to be standing for more than 10 minutes at a time.
Ge Bai, PhD, a professor of health policy and management at Johns Hopkins Bloomberg School of Public Health, says the novelty of long COVID and the continued uncertainty around it raise questions for health insurance providers.
“There’s no well-defined pathway to treat or cure this condition,” Bai says. “Right now, employers have discretion to determine when a condition is being covered or not being covered. So people with long COVID do have a risk that their treatments won’t be covered.”
[ad_2]

[ad_1]
Press play to listen to this article
Russian President Vladimir Putin turned back to his bloody, destructive playbook from Syria with a barrage of rocket attacks against civilian targets across Ukraine on Monday, ramping up pressure on Western allies to supply Kyiv with the air defenses it has long sought.
Monday’s rush-hour bombardment on the streets of Kyiv, Lviv, Dnipro, Zaporizhzhia and other regions came as little surprise, given that Putin had already signaled his willingness to switch to ever more brutal tactics by appointing Sergey Surovikin, the general who oversaw Russian forces in Syria on-and-off from 2017 to 2020, as commander of his struggling war effort in Ukraine.
In a speech at an emergency meeting of his National Security Council on Monday, Putin claimed the strikes came in response to this weekend’s attack on the Kerch Bridge linking illegally occupied Crimea to Russia. Putin said Russia had deployed “high-precision, long-range weapons from the air, sea and land” to deliver “massive attacks on targets of Ukraine’s energy, military command and communications facilities.” He added that Russia would continue to dole out retribution if Ukraine continued to strike so-called “Russian” territory.
Ukraine’s defense ministry said 75 missiles were launched, 41 of which were shot down.
Moscow’s claims to precision attacks on strategic targets seemed to mask the fact that the aim was clearly to kill civilians, as the missiles struck the Shevchenkivskyi district in the heart of Kyiv during peak morning traffic. Pictures and footage taken by reporters and from security cameras show cars on fire; a crater beside a children’s playground in the Shevchenko Park and a pedestrian bridge destroyed.
Ukrainian President Volodymyr Zelenskyy said on Telegram that Russia appeared to have two targets in its assault: energy facilities throughout the country — and Ukrainians going about their daily lives.
“They want panic and chaos,” Zelenskyy said, in a video that appeared to have been shot on his cell phone on the streets of Kyiv. Monday’s attacks came at a time “especially chosen to cause as much damage as possible … Why such strikes exactly? The enemy wants us to be afraid, wants to make people run. But we can only run forward — and we demonstrate this on the battlefield. It will continue to be so.”
Zelenskyy also renewed his appeals to the West to provide Ukraine with additional air defenses. Kyiv has been seeking this additional firepower for weeks, arguing that Russia is likely to try to knock out Ukraine’s energy and industrial infrastructure over the winter, and it has been disappointed by the slow response.
In tweets, Zelenskyy said he had spoken with German Chancellor Olaf Scholz and his French counterpart Emmanuel Macron in the wake of the strikes on the capital and other cities. With Macron, Zelenskyy said: “We discussed the strengthening of our air defense, the need for a tough European and international reaction, as well as increased pressure on the Russian Federation.”
Those discussions on air defense batteries are now likely to loom large at the U.S.-led Ukraine Defense Contact Group — also known as the Ramstein format — where senior defense officials from across the globe will gather in Brussels later this week.
Ukraine’s Defense Minister Oleksii Reznikov said on Monday: “The best response to Russian missile terror is the supply of anti-aircraft and anti-missile systems to Ukraine — protect the sky over Ukraine! This will protect our cities and our people. This will protect the future of Europe. Evil must be punished.”
Surovikin was only announced as the new Russian commander for Ukraine on Saturday.
The 55-year-old general, who before his promotion had been charged with leading Russia’s Southern Military District and Russian troops in Syria, has long been an infamous figure with a reputation for being ruthless.
He was linked to the violent suppression of the anti-Soviet 1990 Dushanbe riots in Tajikistan, and was reportedly imprisoned (before being freed without charge) after soldiers under his command killed three protesters in Moscow during the failed coup against then Soviet President Mikhail Gorbachev in August 1991. In 1995, Surovikin received a suspended sentence (which was later overturned) for participating in the illegal arms trade. Surovikin also played a role in Russia’s second Chechen war, commanding the 42nd Guards Motorized Rifle Division.
But Surovikin is best known — and most feared — for his command of Russian forces in Syria, where Moscow intervened to prop up Bashar al-Assad’s regime. Human Rights Watch, a non-governmental organization, listed Surovikin as one of the commanders “who may bear command responsibility” for human rights violations during the 2019-2020 offensive in Syria’s Idlib province, when Syrian and Russian forces launched dozens of air and ground attacks on civilian targets and infrastructure, striking homes, schools, health care facilities and markets.
It was not the first time Russian forces were accused of war crimes in Syria. The Kremlin’s troops, working with Syrians, undertook a month-long bombing campaign of opposition-controlled territory in Aleppo in 2016, killing hundreds of civilians, including 90 children, with indiscriminate airstrikes, cluster munitions and incendiary weapons hitting civilian targets including medical facilities.
Now, with Russian forces on the back foot in Ukraine and Putin’s full-throated rhetoric out of step with the situation on the ground in his war, Surovikin appears to be turning to his old tactic of inflicting massive damage on civilians in an attempt to turn the tide of the war.
[ad_2]
Zoya Sheftalovich
Source link
[ad_1]
The U.S. is at risk of prolonging the COVID pandemic if it fails to back an initiative that aims to get vaccines, diagnostics and treatments to lower-income countries, a congressional group has told President Joe Biden.
In a letter to Biden from the group led by Earl Blumenauer, a Democrat from Oregon, the group urged him to back the World Trade Organization’s agreement in June to ease exports of lifesaving therapies.
“With more than 600 million shots in arms, 21,500 free testing sites, the ability to order at-home tests for free, and more treatments available now than at any point in the pandemic, the outlook in the United States is better than ever. Unfortunately, however, the prospect for many low-income countries is not so positive — putting the United States’ own success in jeopardy,” the lawmakers wrote.
The letter was sent ahead of a meeting of the WTO council for trade-related aspects of IP rights that is due to kick off Thursday.
The group noted that lower-income countries are facing a higher risk of severe illness, hospitalization and death as only a small percentage of their populations are vaccinated. Just 19% of people in those countries are vaccinated, compared with about 75% in high-income countries, according to the Multilateral Leaders Taskforce on COVID-19, a joint initiative of the International Monetary Fund, the World Bank, the World Health Organization and the WTO.
U.S. known cases of COVID are continuing to ease and now stand at their lowest level since late April, although the true tally is likely higher given how many people are testing at home, where the data are not being collected.
The daily average for new cases stood at 43,149 on Wednesday, according to a New York Times tracker, down 23% from two weeks ago. Cases are rising in most northeastern states by 10% of more, while cases in the western states Montana, Washington and Oregon are rising.
The daily average for hospitalizations was down 11% at 27,184, while the daily average for deaths is down 8% to 391.
Coronavirus Update: MarketWatch’s daily roundup has been curating and reporting all the latest developments every weekday since the coronavirus pandemic began
Other COVID-19 news you should know about:
• China’s huge Xinjiang region has been hit with sweeping COVID travel restrictions ahead of a key Communist Party congress later this month, the Associated Press reported. Trains and buses in and out of the region of 22 million people have been suspended, and passenger numbers on flights have been reduced to 75% of capacity in recent days, according to Chinese media reports. The region is home to minorities who have been forced into prison-like re-education centers to force them to renounce their religion, typically Islam, and allegedly subjected to human-rights abuses.
• Five current or former Internal Revenue Service workers have been charged with fraud for illegally getting money from federal COVID-19 relief programs and using a total of $1 million for luxury items and personal trips, prosecutors said, the AP reported. The U.S. attorney’s office in Memphis said Tuesday that the five have been charged with wire fraud after they filed fake applications for the Paycheck Protection Program and the Economic Injury Disaster Loan Program, which were part of a federal stimulus package tied to the pandemic response in 2020.
• Peloton Interactive Inc.
PTON,
said it plans to cut about 500 jobs, roughly 12% of its remaining workforce, in the company’s fourth round of layoffs this year as the connected fitness-equipment maker tries to reverse mounting losses, the Wall Street Journal reported. After enjoying a strong run early on in the pandemic, Peloton has struggled since the start of the U.S. recovery, and CEO Barry McCarthy, who took over in February, said he is giving the unprofitable company another six months or so to significantly turn itself around and, if it fails, Peloton likely isn’t viable as a stand-alone company.
Don’t miss: Peloton CEO says ‘naysayers’ are looking at the company’s $1.2 billion quarterly loss all wrong.
Here’s what the numbers say:
The global tally of confirmed cases of COVID-19 topped 619.9 million on Wednesday, while the death toll rose above 6.55 million, according to data aggregated by Johns Hopkins University.
The U.S. leads the world with 96.6 million cases and 1,061,490 fatalities.
The Centers for Disease Control and Prevention’s tracker shows that 225.3 million people living in the U.S., equal to 67.9% of the total population, are fully vaccinated, meaning they have had their primary shots. Just 109.9 million have had a booster, equal to 48.8% of the vaccinated population, and 23.9 million of those who are eligible for a second booster have had one, equal to 36.6% of those who received a first booster.
Some 7.6 million people have had a shot of one of the new bivalent boosters that target the new omicron subvariants that have become dominant around the world.
[ad_2]
[ad_1]
A strong fall COVID booster campaign could save about 90,000 people living in the U.S. from dying of the virus and avoid more than 936,000 hospitalizations, according to a new study by the Commonwealth Fund.
As immunity wanes and new variants that can evade protection from early vaccines emerge, surges in hospitalizations and deaths are increasingly likely this fall and winter, the authors wrote. That makes it important that people get the bivalent boosters recently authorized by the Food and Drug Administration and help stop transmission, they wrote.
Researchers analyzed three scenarios to evaluate the impact of vaccination on reducing fatalities, hospitalizations and medical costs to both the Medicare and Medicaid programs.
The first measured the outcome if daily vaccination rates remain unchanged from current levels; they have gradually declined since the first wave of the omicron variant. Federal financial support has also not been replenished, amid a perception among many Americans that the pandemic is over and as congressional Republicans oppose legislative efforts to continue the pandemic fight.
As of Oct. 3, some 68% of the U.S. population has had primary shots, but fewer than half of those have received a booster dose, and only 36% of those aged 50 and older have had a second booster.
The second and third Commonwealth Fund scenarios looked at outcomes if rates increased by the end of 2022.
In one scenario, researchers imagined booster uptake would track flu-shot coverage in 2020 to 2021. The other scenario assumed 80% of eligible individuals 5 and older get a booster by the end of 2022.
The data found that more than 75,000 deaths could be prevented along with more than 745,000 hospitalizations if coverage reaches similar levels to 2021 to 2022 flu vaccination. The best scenario would save $56 billion in direct medical costs over the course of the next six months.
“Stratifying by insurance type, we found direct medical costs would be reduced by $11 billion for Medicare alone under scenario 1 and $13 billion under scenario 2,” the authors wrote. “An additional $3.5 to $4.5 billion in savings would accrue to Medicaid. Even if the federal government paid all vaccination costs, accelerated campaigns would generate more than $10 billion in net savings from federal programs like Medicare and Medicaid.”
The study comes as U.S. known cases of COVID are continuing to ease and now stand at their lowest level since late April, although the true tally is likely higher given how many people are testing at home, with data not being collected.
The daily average for new cases stood at 44,484 on Tuesday, according to a New York Times tracker, down 22% from two weeks ago. Cases are rising in most northeastern states by 10% of more, while cases in the are rising in the western states Montana, Washington and Oregon.
The daily average for hospitalizations was down 12% at 27,334, while the daily average for deaths is down 8% to 393.
Coronavirus Update: MarketWatch’s daily roundup has been curating and reporting all the latest developments every weekday since the coronavirus pandemic began
Other COVID-19 news you should know about:
• Long COVID, a condition that can encompass symptoms such as respiratory distress, cough, “brain fog,” fatigue and malaise that last 12 weeks or longer after initial infection, is becoming a long-term challenge as both employers and workers navigate an ever-mutating virus, according to Liz Seegert, writing for NextAvenue.org. The Centers for Disease Control and Prevention found that one in five COVID survivors younger than 65 experienced at least one incident that might be related to previous COVID-19 infection. Among those 65 and older, the rate was one in four. Their data also show that nearly three times as many people age 50 to 59 currently have long COVID than those 80 or older.
• A retired judge opened a public inquiry on Tuesday into how Britain handled the coronavirus pandemic, saying bereaved families and those who suffered would be at the heart of the proceedings, the Associated Press reported. Former Court of Appeal judge Heather Hallett said the inquiry would investigate the U.K.’s preparedness for a pandemic, how the government responded, and whether the “level of loss was inevitable or whether things could have been done better.”
• Health experts are keeping an eye on new versions of the BA.5 omicron subvariant amid concerns those virus versions can evade the drugs developed to fight COVID, Salon reported. Of particular concern are two named BQ.1 and BQ.1.1, along with BA.2.75.2, which is spreading in Singapore, India and parts of Europe. Then there’s XBB, which some research suggest is the most antibody-evasive strain tested so far. The World Health Organization said in its weekly update on the virus that BA.5 descendent lineages continued to be dominant in the latest week, accounting for 80.8% of sequences shared through a global database. It also noted “increased diversity” within omicron and its lineages.
• Eiger BioPharmaecuticals Inc.
EIGR,
said Wednesday it will not pursue emergency authorization of its experimental treatment for mild and moderate COVID-19 infections. It had asked the Food and Drug Administration to consider an EUA application based on data from the Together trial, a Phase 3 study that has assessed 11 possible treatments for COVID-19 that is being conducted in Brazil and Canada. Eiger said the FDA instead recommended the company consider running its own pivotal trial for peginterferon lambda that would support full approval of the drug.
Here’s what the numbers say:
The global tally of confirmed cases of COVID-19 topped 619.2 million on Wednesday, while the death toll rose above 6.55 million, according to data aggregated by Johns Hopkins University.
The U.S. leads the world with 96.5 million cases and 1,060,446 fatalities.
The Centers for Disease Control and Prevention’s tracker shows that 225.3 million people living in the U.S., equal to 67.9% of the total population, are fully vaccinated, meaning they have had their primary shots. Just 109.9 million have had a booster, equal to 48.8% of the vaccinated population, and 23.9 million of those who are eligible for a second booster have had one, equal to 36.6% of those who received a first booster.
Some 7.6 million people have had a shot of the new bivalent booster that targets the new omicron subvariants that have become dominant around the world.
[ad_2]
[ad_1]
The Republican Party has an edge again in the generic ballot, and that advantage has reached a level last seen in late July, according to a RealClearPolitics average for that closely watched indicator.
That could be another sign that the GOP may be getting back some momentum as November’s midterm elections approach, after Democratic prospects improved during the summer.
Republicans are now scoring 46.0% support in the RCP average of generic ballots, a percentage point ahead of Democrats at 45.0%.
The GOP hit a 1-point edge last Wednesday, then saw a dip, but as of Tuesday was back at that level, as shown in the chart below.
It’s not a big advantage, but it’s the best showing for Republicans in RCP’s data for generic ballots since July 28, as Democrats had the advantage for much of August and September.
Related: If this seat flips red, Republicans will have ‘probably won a relatively comfortable House majority’
Also read: ‘Republican control of the House is not a foregone conclusion,’ says political analyst
The generic ballot refers to a poll question that asks voters which party they would support in a congressional election without naming individual candidates. Analysts tend to see it as a useful indicator.
Other websites focused on political analysis and forecasting, such as FiveThirtyEight, still show Democrats with an edge in their data for generic ballots.
Election Day for the midterm contests is now five weeks away. Democrats have focused their campaigns on abortion rights after the Supreme Court’s June decision that overturned Roe v. Wade, while Republicans have seized on Americans’ frustration with high inflation.
The additional chart below is interactive and shows RCP’s data for the generic ballot over a longer time frame.
And see: New poll finds just 30% of Americans approve of how Biden is handling inflation
[ad_2]
[ad_1]
The U.S. Centers for Disease Control and Prevention has dropped its country-by-country COVID-19 travel health notices that it began issuing early in the pandemic, the Associated Press reported.
The reason: Fewer countries are testing for the virus or reporting the number of COVID cases. That limits the CDC’s ability to calculate travelers’ risk, according to the agency.
CDC spokeswoman Kristen Nordlund said the agency will only post a travel health notice for an individual country if a situation such as a troubling new variant of the virus changes CDC travel recommendations for that country.
The CDC still recommends that travelers remain up-to-date on vaccines and follow recommendations found on its international travel page.
From the CDC: Stay Up to Date with COVID-19 Vaccines Including Boosters
A new study from the National Bureau of Economic Research has confirmed that political affiliations played a key role as a risk factor for dying of COVID, finding evidence that Republican-leaning counties suffered higher death rates than Democratic-leaning ones.
“We estimate substantially higher excess death rates for registered
Republicans when compared to registered Democrats, with almost all of the difference concentrated in the period after vaccines were widely available in our study states,” the authors, Jacob Wallace and Jason L. Schwartz of the Yale School of Public Health, and Paul Goldsmith-Pinkham of the Yale School of Management wrote.
“Overall, the excess death rate for Republicans was 5.4 percentage points (pp), or 76%, higher than the excess death rate for Democrats.”
The researchers used data from Ohio and Florida and matched 2017 voter registration data with mortality data from 2018 to 2021. They also found a link between political affiliation and views on vaccines, with Republican-leaning counties showing far lower vaccination rates.
In the U.S., known cases of COVID are continuing to ease and now stand at their lowest level since late April, although the true tally is likely higher given how many people are testing at home, where the data are not being collected.
The daily average for new cases stood at 45,495 on Monday, according to a New York Times tracker, down 24% from two weeks ago. Cases are rising in 11 states plus Washington, D.C. They are up by double-digit percentages in Rhode Island, Massachusetts and Vermont.
The daily average for hospitalizations was down 11% at 27,854, while the daily average for deaths is down 12% to 386.
Coronavirus Update: MarketWatch’s daily roundup has been curating and reporting all the latest developments every weekday since the coronavirus pandemic began
Other COVID-19 news you should know about:
• Norwegian Cruise Line Holdings Ltd.
NCLH,
is removing all COVID testing, vaccination and masking requirements from its health and safety protocols. The company said the new protocols, which follows “significant, positive progress” in the public health environment, will be effective Oct. 4. “Health and safety are always our first priority; in fact, we were the health and safety leaders from the very start of the pandemic,” said Chief Executive Harry Sommer. “Many travelers have been patiently waiting to take their long-awaited vacation at sea and we cannot wait to celebrate their return.”
• Ringo Starr has test positive for COVID, forcing the former Beatle to cancel scheduled concerts in Canada with his All Starr Band, the AP reported. Five concert dates from Tuesday to Sunday — in Winnipeg, Manitoba; Saskatoon, Saskatchewan; Lethbridge, Alberta; and the British Columbia cities of Abbotsford and Penticton — will be rescheduled. “Ringo hopes to resume as soon as possible and is recovering at home. As always, he and the All Starrs send peace and love to their fans and hope to see them back out on the road soon,” said a statement from the band.
• A federal appeals court in New Orleans on Monday became the latest to hear arguments on whether President Joe Biden overstepped his authority with an order that federal contractors require that their employees be vaccinated against COVID, the AP reported separately. The contractor mandate has a complicated legal history. It is being challenged in more than a dozen federal court districts, and the mandate has been blocked or partially blocked in 25 states.
• The Chinese resort city of Sanya has ordered all tourists to take PCR tests, and those who fail to do so by noon on Tuesday will be slapped with a yellow code restricting their mobility, according to local officials, the South China Morning Post reported. The city in the southern province of Hainan logged two asymptomatic Covid-19 cases on Monday. It carried out a round of mass testing and locked down several areas in Haitang district, including a scenic island that received around 2,000 tourists on Monday.
Here’s what the numbers say:
The global tally of confirmed cases of COVID-19 topped 618.7 million on Tuesday, while the death toll rose above 6.54 million, according to data aggregated by Johns Hopkins University.
The U.S. leads the world with 96.4 million cases and 1,059,888 fatalities.
The Centers for Disease Control and Prevention’s tracker shows that 225.3 million people living in the U.S., equal to 67.9% of the total population, are fully vaccinated, meaning they have had their primary shots. Just 109.9 million have had a booster, equal to 48.8% of the vaccinated population, and 23.9 million of those who are eligible for a second booster have had one, equal to 36.6% of those who received a first booster.
Some 7.6 million people have had a shot of the new bivalent booster that targets the new omicron subvariants that have become dominant around the world.
[ad_2]